Interim report for the three months ended March 31, 2007

| Source: Affitech A/S Affitech A/S 

Summary: For the first three months of 2007 the Pharmexa Group generated
revenues and other operating income of DKK 4,614 thousand and a net loss of DKK
47,886 thousand. Research and development costs totalled DKK 45,658 thousand.
The Pharmexa Group retains its forecast for the full year.

Attachments

pharmexa press release 2007-17-uk.pdf